Cheng, Charles

Publishing since 1978 (Dinosaur)

Has published 220 publications in 33 years

Number of publications published per year by Cheng, Charles. (Source : PubMed)

Distribution of publications types for Cheng, Charles. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Wang P, Sun L, Shen A, Yang J, Li X, Liu H, Tao T, Cheng C, Lu X. Involvement of Src-Suppressed C Kinase Substrate in Neuronal Death Caused by the Lipopolysaccharide-Induced Reactive Astrogliosis.  Inflammation  2010  
•  Bailey KR, Cheng C. Conference Scene: The great debate: genome-wide association studies in pharmacogenetics research, good or bad?  Pharmacogenomics  2010;11;3  
•  Stone RA, Rao RH, Sevick MA, Cheng C, Hough LJ, Macpherson DS, Franko CM, Anglin RA, Obrosky DS, Derubertis FR. Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial.  Diabetes Care  2010;33;3  
•  Pan J, Cheng C, Verstovsek S, Chen Q, Jin Y, Cao Q. The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells.  Cancer Lett.  2010  
•  Chick CM, Tan BS, Cheng C, Taneja M, Lo R, Tan YH, Lin SE, Tay KH. Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol.  BJU Int.  2010;105;3  
•  He S, Lu M, Xue W, Wang Y, Zhao Y, Gao S, Ke Q, Liu Y, Li P, Cui X, Cheng C, Shen A. Phosphorylated p27(Kip1) on Thr157 is an important prognosis in human hepatocellular carcinoma in vivo and in vitro.  Med. Oncol.  2010  
•  Cheng C, Gall JG, Nason M, King CR, Koup RA, Roederer M, McElrath MJ, Morgan CA, Churchyard G, Baden LR, Duerr AC, Keefer MC, Graham BS, Nabel GJ. Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.  J. Virol.  2010;84;1  
•  Liu X, Nguyen P, Liu W, Cheng C, Steeves M, Obenauer JC, Ma J, Geiger TL. T cell receptor CDR3 sequence but not recognition characteristics distinguish autoreactive effector and Foxp3(+) regulatory T cells.  Immunity  2009;31;6  
•  Treviño LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, Chan D, Sparreboom A, Giacomini KM, Pui CH, Evans WE, Relling MV. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.  J. Clin. Oncol.  2009;27;35  
•  Watters JW, Cheng C, Majumder PK, Wang R, Yalavarthi S, Meeske C, Kong L, Sun W, Lin J, Heyer J, Ware C, Winter C, Reilly JF, Demuth T, Clark S, Chiu MI, Robinson MO, Kohl N, Kannan K. De novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor model.  Cancer Res.  2009;69;23  

[ See timeline ] [ See all publications ]